Literature DB >> 18364054

Reproducibility and validity of a handheld spirometer.

R Graham Barr1, Kimberly J Stemple, Sonia Mesia-Vela, Robert C Basner, Susan J Derk, Paul K Henneberger, Donald K Milton, Brenda Taveras.   

Abstract

BACKGROUND: Handheld spirometers have several advantages over desktop spirometers, but worries persist regarding reproducibility and validity of data from handheld spirometers. We undertook an independent examination of the EasyOne handheld spirometer.
METHODS: The laboratory testing included reproducibility and validity testing with a waveform generator. We used standard American Thoracic Society waveforms for in-line testing, calibration adaptor testing, and testing during compression of the mouthpiece. The clinical testing involved repeated tests with 24 spirometry-naïve volunteers and comparison to spirometry results from laboratory (volume-sensing dry rolling seal) spirometer.
RESULTS: The EasyOne exceeded standard thresholds for acceptability with the American Thoracic Society waveforms. In-line testing yielded valid results from the EasyOne. Between the EasyOne and the reference spirometer readings the mean +/- SD difference was 0.03 +/- 0.23 L for forced vital capacity (FVC) and -0.06 +/- 0.09 L for forced expiratory volume in the first second (FEV(1)). The calibration adaptor showed no appreciable problems. Extreme compression of the mouthpiece reduced the measured values. In clinical testing the coefficients of variation and limits of agreement were, respectively, 3.3% and 0.24 L for FVC, 2.6% and 0.18 L for FEV(1), and 1.9% and 0.05 for the FEV(1)/FVC ratio. The EasyOne readings were lower than those from the reference spirometer; the differences were: -0.12 L for FVC, -0.17 L for FEV(1), and -0.02 for FEV(1)/FVC. The limits of agreement were within criteria for FVC but not for the FEV(1), possibly due to a training effect.
CONCLUSION: The EasyOne spirometer yielded generally reproducible results that were generally valid, compared to the values from the laboratory spirometer. The use of the EasyOne in clinical, occupational, and research settings seems justified.

Mesh:

Year:  2008        PMID: 18364054      PMCID: PMC3595551     

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  16 in total

Review 1.  Beyond the peak flow meter: newer technologies for determining and documenting changes in lung function in the workplace.

Authors:  J L Hankinson
Journal:  Occup Med       Date:  2000 Apr-Jun

Review 2.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Authors:  G T Ferguson; P L Enright; A S Buist; M W Higgins
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

3.  Performance of a new screening spirometer at a community health fair.

Authors:  Robin J Schoh; Laura J Fero; Howard Shapiro; Jordan P Aslor; Oscar J Kaelin; Donald R Rollins; Thomas L Petty
Journal:  Respir Care       Date:  2002-10       Impact factor: 2.258

4.  Physical health status of World Trade Center rescue and recovery workers and volunteers - New York City, July 2002-August 2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-09-10       Impact factor: 17.586

5.  Evaluating the use of a portable spirometer in a study of pediatric asthma.

Authors:  Kathleen M Mortimer; Andre Fallot; John R Balmes; Ira B Tager
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

8.  Volume spirometers need automated internal temperature sensors.

Authors:  L R Johnson; P L Enright; H T Voelker; D P Tashkin
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

Review 9.  Strategies for screening for chronic obstructive pulmonary disease.

Authors:  Paul L Enright; David A Kaminsky
Journal:  Respir Care       Date:  2003-12       Impact factor: 2.258

10.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Earl S Ford; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-08-02
View more
  23 in total

1.  Spirometry in primary care for case finding and management of chronic obstructive pulmonary disease primary care diagnostic technology update.

Authors:  Gary Parkes; Annette Plüddemann; Carl Heneghan; Christopher P Price; Jane Wolstenholme; Matthew Thompson
Journal:  Br J Gen Pract       Date:  2011-11       Impact factor: 5.386

2.  Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study.

Authors:  R Graham Barr; Sonia Mesia-Vela; John H M Austin; Robert C Basner; Brad M Keller; Anthony P Reeves; Daichi Shimbo; Lori Stevenson
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

3.  Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:  Guang-Shing Cheng; Angela P Campbell; Hu Xie; Zach Stednick; Cheryl Callais; Wendy M Leisenring; Janet A Englund; Jason W Chien; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-31       Impact factor: 5.742

4.  Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers.

Authors:  Sonia Mesia-Vela; Chih-Ching Yeh; John H M Austin; Matthew Dounel; Charles A Powell; Anthony Reeves; Regina M Santella; Lori Stevenson; David Yankelevitz; R Graham Barr
Journal:  Biomarkers       Date:  2008-06       Impact factor: 2.658

5.  A Pilot Study to Assess the Feasibility of Collecting and Transmitting Clinical Trial Data with Mobile Technologies.

Authors:  Colleen Russell; Nadir Ammour; Toby Wells; Nicolas Bonnet; Matthias Kruse; Agnes Tardat; Christel Erales; Thomas Shook; Stephane Kirkesseli; Lionel Hovsepian; Sy Pretorius
Journal:  Digit Biomark       Date:  2018-11-07

6.  Change in plasma α-tocopherol associations with attenuated pulmonary function decline and with CYP4F2 missense variation.

Authors:  Jiayi Xu; Kristin A Guertin; Nathan C Gaddis; Anne H Agler; Robert S Parker; Jared M Feldman; Alan R Kristal; Kathryn B Arnold; Phyllis J Goodman; Catherine M Tangen; Dana B Hancock; Patricia A Cassano
Journal:  Am J Clin Nutr       Date:  2022-04-01       Impact factor: 7.045

7.  A randomized controlled trial of vitamin E and selenium on rate of decline in lung function.

Authors:  Patricia A Cassano; Kristin A Guertin; Alan R Kristal; Kathryn E Ritchie; Monica L Bertoia; Kathryn B Arnold; John J Crowley; JoAnn Hartline; Phyllis J Goodman; Catherine M Tangen; Lori M Minasian; Scott M Lippman; Eric Klein
Journal:  Respir Res       Date:  2015-03-11

8.  Air pollution exposure and lung function in highly exposed subjects in Beijing, China: a repeated-measure study.

Authors:  Andrea A Baccarelli; Yinan Zheng; Xiao Zhang; Dou Chang; Lei Liu; Katherine Rose Wolf; Zhou Zhang; John P McCracken; Anaité Díaz; Pier Alberto Bertazzi; Joel Schwartz; Sheng Wang; Choong-Min Kang; Petros Koutrakis; Lifang Hou
Journal:  Part Fibre Toxicol       Date:  2014-10-02       Impact factor: 9.400

9.  Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study.

Authors:  Mohamed Manji; Grace Shayo; Simon Mamuya; Rose Mpembeni; Ahmed Jusabani; Ferdinand Mugusi
Journal:  BMC Pulm Med       Date:  2016-04-23       Impact factor: 3.317

10.  Emphysema predicts hospitalisation and incident airflow obstruction among older smokers: a prospective cohort study.

Authors:  David A McAllister; Firas S Ahmed; John H M Austin; Claudia I Henschke; Brad M Keller; Adina Lemeshow; Anthony P Reeves; Sonia Mesia-Vela; G D N Pearson; Maria C Shiau; Joseph E Schwartz; David F Yankelevitz; R Graham Barr
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.